Found: 66
Select item for more details and to access through your institution.
Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 953, doi. 10.1007/s00262-011-1004-8
- By:
- Publication type:
- Article
Long-Term Survival in Patients With Advanced Melanoma.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
- By:
- Publication type:
- Article
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF).
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1403687
- By:
- Publication type:
- Article
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0261939
- By:
- Publication type:
- Article
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers.
- Published in:
- Applied Health Economics & Health Policy, 2022, v. 20, n. 5, p. 717, doi. 10.1007/s40258-022-00740-1
- By:
- Publication type:
- Article
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
- By:
- Publication type:
- Article
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 2, p. 1130, doi. 10.1245/s10434-020-08741-x
- By:
- Publication type:
- Article
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades.
- Published in:
- European Journal of Endocrinology, 2020, v. 183, n. 2, p. 203, doi. 10.1530/EJE-20-0080
- By:
- Publication type:
- Article
Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 12, p. 3154, doi. 10.3390/diagnostics12123154
- By:
- Publication type:
- Article
The Value of 18 F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 715, doi. 10.3390/diagnostics12030715
- By:
- Publication type:
- Article
Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with 'untargeted' side effects.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
- Published in:
- 2013
- By:
- Publication type:
- Letter
Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 5, p. 941, doi. 10.3109/0284186X.2012.739730
- By:
- Publication type:
- Article
Severe colitis while responding to ipilimumab in metastatic melanoma.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038287
- By:
- Publication type:
- Article
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1673, doi. 10.1002/cncr.35178
- By:
- Publication type:
- Article
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer.
- Published in:
- Drugs & Aging, 2019, v. 36, n. 10, p. 927, doi. 10.1007/s40266-019-00697-2
- By:
- Publication type:
- Article
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8<sup>+</sup> T cell response.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 254, p. 1, doi. 10.1126/scitranslmed.3008918
- By:
- Publication type:
- Article
Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 8, p. 3758, doi. 10.1210/jc.2009-2507
- By:
- Publication type:
- Article
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease.
- Published in:
- 2021
- By:
- Publication type:
- letter
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3123, doi. 10.1007/s00262-021-02871-1
- By:
- Publication type:
- Article
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 5, p. 449, doi. 10.1007/s00262-014-1528-9
- By:
- Publication type:
- Article
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5419, doi. 10.3390/cancers15225419
- By:
- Publication type:
- Article
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922
- By:
- Publication type:
- Article
Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990–2019).
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1541, doi. 10.3390/cancers15051541
- By:
- Publication type:
- Article
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 409, doi. 10.3390/cancers15020409
- By:
- Publication type:
- Article
Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5426, doi. 10.3390/cancers14215426
- By:
- Publication type:
- Article
Time Trends in Treatment Strategies and Survival of Older versus Younger Patients with Synchronous Metastasised Melanoma—A Population-Based Study in the Netherlands Cancer Registry.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4904, doi. 10.3390/cancers14194904
- By:
- Publication type:
- Article
Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1366, doi. 10.3390/cancers14061366
- By:
- Publication type:
- Article
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6366, doi. 10.3390/cancers13246366
- By:
- Publication type:
- Article
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5077, doi. 10.3390/cancers13205077
- By:
- Publication type:
- Article
Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4639, doi. 10.3390/cancers13184639
- By:
- Publication type:
- Article
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2440, doi. 10.3390/cancers13102440
- By:
- Publication type:
- Article
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1104, doi. 10.3390/cancers13051104
- By:
- Publication type:
- Article
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2072, doi. 10.3390/cancers12082072
- By:
- Publication type:
- Article
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1176, doi. 10.3390/cancers12051176
- By:
- Publication type:
- Article
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1003, doi. 10.3390/cancers12041003
- By:
- Publication type:
- Article